下一代肿瘤不可知靶点即将出现
Next-generation tumor-agnostic targets on the horizon.
肿瘤不可知药物开发将肿瘤学重新聚焦于共享的分子依赖性而非组织来源,从而能够针对跨肿瘤的罕见可操作驱动因素进行高效开发。
英文原题:γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer.
γδ T Cell-Mediated Immune Responses for Cancer Therapy: Special Focus on Breast Cancer.
三阴性乳腺癌(TNBC)是一种侵袭性强的乳腺癌(BC),缺乏雌激素和孕激素受体,且HER2/neu蛋白过表达。
三阴性乳腺癌(TNBC)是一种具有高度侵袭性的乳腺癌(BC),缺乏雌激素和孕激素受体,并伴有HER2/neu蛋白过表达。它比其他类型的BC更具侵袭性,常见于年轻女性。近年来,临床前和临床研究已探索使用免疫疗法治疗TNBC患者。然而,由于高水平的肿瘤突变负荷,只有一部分患者对免疫治疗有应答。肿瘤微环境(TME)细胞之间通过信号分子的双向通讯调节γδ T细胞,以支持或损害肿瘤生长。本综述强调γδ T细胞介导的免疫反应,特别关注乳腺癌。我们介绍了γδ T细胞的细胞毒性特征。我们还介绍了γδ T细胞在TME中引发促肿瘤和抗肿瘤反应的重要作用。最后,我们的综述聚焦于γδ T细胞作为乳腺癌发展中的祸害的显著特征。
Triple-negative breast cancer (TNBC) is a type of breast cancer (BC) with high aggressive nature, devoid of receptors for estrogen and progesterone hormones and with overexpression of the HER2/neu protein. It is more aggressive than other types of BC, common occurring in younger women. Recently, preclinical and clinical studies have investigated the use of immune therapies to treat TNBC patients. However, a subset of patients is responding to immunotherapy due to the high level of tumor mutation burden. The bidirectional communication among the tumor microenvironment (TME) cells via signal molecules modulates γδ T cells to support or impair tumor growth. This review emphasizes γδ T cell-mediated immune responses with a special focus on breast cancer. We present the cytotoxic characteristics of γδ T cells. We also present the promising role of γδ T cells in mounting pro-tumor and anti-tumor responses in the TME. Finally, our review focuses on prominent features of γδ T cells as a curse in breast cancer development.
MEMBER ACCOUNT
登录成功会直接打开下一页。